Clinical Trials in San Francisco

Showing 1381-1400 of 11,161 trials

Wellness, Intervention Strategies and HIV Care

NCT07069374

This is a pilot trial designed to assess the feasibility and acceptability of an intervention aimed at improving adherence to antiretroviral therapy (ART), viral suppression, and engagement in HIV care. The intervention will address behavioral coping strategies, HIV care engagement behaviors, and substance use management.

HIVSubstance Use Disorder (SUD)

University of California, San Francisco50 participantsStarted Sep 2025

Oakland, California, United States • San Francisco, California, United States

COMPLETEDPhase 2< 1 mile

Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder

NCT02900976

This pilot phase II trial studies how well rituximab and latent membrane protein (LMP)-specific T-cells work in treating pediatric solid organ recipients with Epstein-Barr virus-positive, cluster of differentiation (CD)20-positive post-transplant lymphoproliferative disorder. Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. LMP-specific T-cells are special immune system cells trained to recognize proteins found on post-transplant lymphoproliferative disorder tumor cells if they are infected with Epstein-Barr virus. Giving rituximab and LMP-specific T-cells may work better in treating pediatric organ recipients with post-transplant lymphoproliferative disorder than rituximab alone.

Children's Oncology Group18 participantsStarted Mar 2017

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Loma Linda, California, United States +35 more locations

Wellness, Intervention Strategies and HIV Care

Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder

Find Trials by Condition in San Francisco

Impact of Ocrelizumab on Cerebrospinal Fluid Biomarkers at Multiple Sclerosis Onset

Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer

Group-based Integrative Pain Management in Primary Care Safety Net Clinics

Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study

Registry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction

A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer

Social & Contextual Impact on Children Undergoing Liver Transplantation

Efficacy and Safety of Tezepelumab in Participants With Severe Chronic Rhinosinusitis With Nasal Polyposis

Immersive Technology to Improve Physical Therapy Engagement

Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1

Peripheral Neurostimulation for Nerve Block Placement

GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

Doxycycline for Emphysema in People Living With HIV (The DEPTH Trial)

First-in-Human Study of ICT01 in Patients With Advanced Cancer

Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma

Deep Brain Stimulation of Treatment-Resistant Bipolar Depression

Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR